File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: 2018 Kidney Disease: Improving Global Outcomes (KDIGO) Hepatitis C in Chronic Kidney Disease Guideline Implementation: Asia Summit Conference Report

Title2018 Kidney Disease: Improving Global Outcomes (KDIGO) Hepatitis C in Chronic Kidney Disease Guideline Implementation: Asia Summit Conference Report
Authors
Keywordschronic kidney disease
dialysis
direct-acting antiviral
infection control
kidney transplantation
Issue Date2020
PublisherElsevier Inc. The Journal's web site is located at http://www.journals.elsevier.com/kidney-international-reports/
Citation
Kidney International Reports, 2020, v. 5 n. 8, p. 1129-1138 How to Cite?
AbstractIn 2018, Kidney Disease: Improving Global Outcomes (KDIGO) published a clinical practice guideline on the prevention, diagnosis, evaluation, and treatment of hepatitis C virus (HCV) infection in chronic kidney disease (CKD). The guideline synthesized recent advances, especially in HCV therapeutics and diagnostics, and provided clinical recommendations and suggestions to aid healthcare providers and improve care for CKD patients with HCV. To gain insight into the extent that the 2018 guideline has been adopted in Asia, KDIGO convened an HCV Implementation Summit in Hong Kong. Participants included nephrologists, hepatologists, and nurse consultants from 8 Southeast Asian countries or regions with comparable high-to-middle economic ranking by the World Bank: mainland China, Hong Kong, Japan, Malaysia, Singapore, South Korea, Taiwan, and Thailand. Through presentations and discussions, meeting participants described regional practice patterns related to the KDIGO HCV in CKD guideline, identified barriers to implementing the guideline, and developed strategies for overcoming the barriers in Asia and around the world.
DescriptionMeeting report
Persistent Identifierhttp://hdl.handle.net/10722/286250
ISSN
2019 Impact Factor: 3.374
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorLi, PKT-
dc.contributor.authorBavanandan, S-
dc.contributor.authorMohamed, R-
dc.contributor.authorSzeto, CC-
dc.contributor.authorWong, VWS-
dc.contributor.authorChow, KM-
dc.contributor.authorDan, YY-
dc.contributor.authorHuang, CC-
dc.contributor.authorLai, CL-
dc.contributor.authorTanwandee, T-
dc.contributor.authorTeo, BW-
dc.contributor.authorWong, GLH-
dc.contributor.authorYeoh, EK-
dc.contributor.authorIseki, K-
dc.contributor.authorLeung, CB-
dc.contributor.authorPark, HC-
dc.contributor.authorKanjanabuch, T-
dc.contributor.authorLu, W-
dc.contributor.authorFung, J-
dc.contributor.authorJia, J-
dc.contributor.authorKanda, E-
dc.contributor.authorLaw, MC-
dc.contributor.authorLiu, H-
dc.contributor.authorLoo, CK-
dc.contributor.authorMak, SK-
dc.contributor.authorLui, SL-
dc.contributor.authorTang, HL-
dc.contributor.authorWang, AYM-
dc.contributor.authorYu, ML-
dc.contributor.authorCheung, M-
dc.contributor.authorJadoul, M-
dc.date.accessioned2020-08-31T07:01:17Z-
dc.date.available2020-08-31T07:01:17Z-
dc.date.issued2020-
dc.identifier.citationKidney International Reports, 2020, v. 5 n. 8, p. 1129-1138-
dc.identifier.issn2468-0249-
dc.identifier.urihttp://hdl.handle.net/10722/286250-
dc.descriptionMeeting report-
dc.description.abstractIn 2018, Kidney Disease: Improving Global Outcomes (KDIGO) published a clinical practice guideline on the prevention, diagnosis, evaluation, and treatment of hepatitis C virus (HCV) infection in chronic kidney disease (CKD). The guideline synthesized recent advances, especially in HCV therapeutics and diagnostics, and provided clinical recommendations and suggestions to aid healthcare providers and improve care for CKD patients with HCV. To gain insight into the extent that the 2018 guideline has been adopted in Asia, KDIGO convened an HCV Implementation Summit in Hong Kong. Participants included nephrologists, hepatologists, and nurse consultants from 8 Southeast Asian countries or regions with comparable high-to-middle economic ranking by the World Bank: mainland China, Hong Kong, Japan, Malaysia, Singapore, South Korea, Taiwan, and Thailand. Through presentations and discussions, meeting participants described regional practice patterns related to the KDIGO HCV in CKD guideline, identified barriers to implementing the guideline, and developed strategies for overcoming the barriers in Asia and around the world.-
dc.languageeng-
dc.publisherElsevier Inc. The Journal's web site is located at http://www.journals.elsevier.com/kidney-international-reports/-
dc.relation.ispartofKidney International Reports-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectchronic kidney disease-
dc.subjectdialysis-
dc.subjectdirect-acting antiviral-
dc.subjectinfection control-
dc.subjectkidney transplantation-
dc.title2018 Kidney Disease: Improving Global Outcomes (KDIGO) Hepatitis C in Chronic Kidney Disease Guideline Implementation: Asia Summit Conference Report-
dc.typeArticle-
dc.identifier.emailLai, CL: hrmelcl@hkucc.hku.hk-
dc.identifier.emailFung, J: jfung@HKUCC-COM.hku.hk-
dc.identifier.emailLui, SL: sllui@hkucc.hku.hk-
dc.identifier.authorityLai, CL=rp00314-
dc.identifier.authorityFung, J=rp00518-
dc.identifier.authorityWang, AYM=rp02174-
dc.description.naturepublished_or_final_version-
dc.identifier.doi10.1016/j.ekir.2020.05.001-
dc.identifier.scopuseid_2-s2.0-85088255142-
dc.identifier.hkuros313818-
dc.identifier.volume5-
dc.identifier.issue8-
dc.identifier.spage1129-
dc.identifier.epage1138-
dc.identifier.isiWOS:000558177600003-
dc.publisher.placeUnited States-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats